{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:21:08Z","timestamp":1772932868380,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.msard.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T22:39:08Z","timestamp":1434580748000},"page":"334-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Pabitra","family":"Basnyat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-7736","authenticated-orcid":false,"given":"Sanna","family":"Hagman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Kolasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keijo","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auli","family":"Verkkoniemi-Ahola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Elovaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2015.06.008_bib1","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/tcrm.2007.3.2.259","article-title":"Natalizumab: a new treatment for relapsing remitting multiple sclerosis","volume":"3","author":"Hutchinson","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.msard.2015.06.008_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.msard.2015.06.008_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.msard.2015.06.008_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2015.06.008_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1479-5876-10-248","article-title":"JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients","volume":"10","author":"Mancuso","year":"2012","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.msard.2015.06.008_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.21630","article-title":"Opportunistic infections and other risks with newer multiple sclerosis therapies","volume":"65","author":"Berger","year":"2009","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737175.2014.874289","article-title":"Biomarkers of treatment response in multiple sclerosis","volume":"14","author":"Buck","year":"2014","journal-title":"Expert Rev. Neurother."},{"issue":"20","key":"10.1016\/j.msard.2015.06.008_bib9","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2015.06.008_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/CMR.05031-11","article-title":"Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain","volume":"25","author":"Ferenczy","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.msard.2015.06.008_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/WNL.0b013e3182a351fb","article-title":"L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients","volume":"81","author":"Schwab","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2015.06.008_bib12","first-page":"213","article-title":"L-selectin in inflammation, infection and immunity","volume":"2","author":"Raffler","year":"2005","journal-title":"Drug Discov.Today: Ther. Strateg."},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1582-4934.2005.tb00354.x","article-title":"L-selectin: mechanisms and physiological significance of ectodomain cleavage","volume":"9","author":"Smalley","year":"2005","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.msard.2015.06.008_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2015.06.008_bib15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","article-title":"A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification","volume":"57","author":"Lee","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.msard.2015.06.008_bib17","article-title":"JC-virus seroconversion in multiple sclerosis patients receiving natalizumab","author":"Outteryck","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2015.06.008_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24286","article-title":"Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML","author":"Plavina","year":"2014","journal-title":"Ann. Neurol."},{"issue":"22","key":"10.1016\/j.msard.2015.06.008_bib19","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2015.06.008_bib20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/428949","article-title":"Levels of L-selectin (CD62L) on human leukocytes in disseminated cryptococcosis with and without associated HIV-1 infection","volume":"191","author":"Jackson","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.msard.2015.06.008_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2014.08.067","article-title":"JCV index and l-selectin for natalizumab-associated PML risk stratification","volume":"275","author":"Schwab","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2015.06.008_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1074-7613(01)00110-8","article-title":"CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis","volume":"14","author":"Grewal","year":"2001","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(94)90023-X","article-title":"Myelin localization of a central nervous system ligand for l-selectin","volume":"53","author":"Huang","year":"1994","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.msard.2015.06.008_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejcb.2011.02.007","article-title":"L-selectin \u2013 a dynamic regulator of leukocyte migration","volume":"91","author":"Wedepohl","year":"2012","journal-title":"Eur. J. Cell. Biol."},{"issue":"8","key":"10.1016\/j.msard.2015.06.008_bib25","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.4049\/jimmunol.0902925","article-title":"ADAM17 activity and other mechanisms of soluble l-selectin production during death receptor-induced leukocyte apoptosis","volume":"184","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2015.06.008_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/eji.1830220524","article-title":"Rapid activation-independent shedding of leukocyte L-selectin induced by cross-linking of the surface antigen","volume":"22","author":"Palecanda","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2015.06.008_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biocel.2012.12.023","article-title":"Signals regulating L-selectin-dependent leucocyte adhesion and transmigration","volume":"45","author":"Ivetic","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.msard.2015.06.008_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1083\/jcb.119.1.229","article-title":"Soluble L-selectin is present in human plasma at high levels and retains functional activity","volume":"119","author":"Schleiffenbaum","year":"1992","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.msard.2015.06.008_bib29","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/122.12.2297","article-title":"Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules","volume":"122","author":"Duran","year":"1999","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1600-0404.2000.102002114.x","article-title":"Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus","volume":"102","author":"Baraczka","year":"2000","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.msard.2015.06.008_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-5728(96)00003-3","article-title":"Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques","volume":"65","author":"Mossner","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.msard.2015.06.008_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.410380210","article-title":"Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging","volume":"38","author":"Hartung","year":"1995","journal-title":"Ann. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:38:37Z","timestamp":1761899917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034815000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2211034815000796"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2015.06.008","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}